Clinical Pharmacology - D01000116

• Title: VP - Klinická farmakologie
• Guaranteed by: Department of Pharmacology (13-311)
• Faculty: Second Faculty of Medicine
• Actual: from 2015
• Semester: summer
• Points: 3
• E-Credits: 3
• Examination process: summer s.:
• Hours per week, examination: summer s.:0/20, C [HT]
• Extent per academic year: 1 [weeks]
• Capacity: unknown / unknown (unknown)
• Min. number of students: unlimited
• 4EU+: no
• Virtual mobility / capacity: no
• State of the course: not taught
• Language: Czech
• Teaching methods: full-time
• Teaching methods: full-time
• Note: course can be enrolled in outside the study plan
• Guarantor: doc. MUDr. Zoltán Paluch, Ph.D., MBA

Literature

Last update: Marie Havlová (22.09.2015)

Následující příručky jsou k dispozici účastníkům:
Chatu: The Hands-on Guide to Clinical Pharmacology ISBN-13: 978-1405191951

Ebadi: Desk Reference of Clinical Pharmacology ISBN-13: 978-1420047431

Wecker, Lynn: Brody's human pharmacology: molecular to clinical. Philadelphia, Mosby Elsevier, 5th ed. ISBN 978-0-323-05374-7

Hyacinth Martin: Clinical Decision Making: Case Studies in Pharmacology ISBN-13: 978-1401835217

A textbook of clinical pharmacology and therapeutics / London: Hodder Arnold, 2008. 5th ed. ISBN 978-0340900468

Clinical pharmacology / Bennett, P. N. Edinburgh; New York: Churchill Livingstone, 10th ed. ISBN 9780443102448

Applying medication math skills: a dimensional analysis approach / Karen Clement-O'Brien, Gary M. Lawler. Albany: Delmar Publishers, c1999.

Applied therapeutics: the clinical use of drugs / edited by Mary Anne Koda-Kimble ... [et al.]. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, c2009.

Syllabus

Last update: Marie Havlová (22.09.2015)

Syllabus - Clinical Pharmacology

Day 1.

Introduction to Clinical Pharmacology

Good Clinical practice

Phases of Clinical trials in human subjects I-IV

Pharmaceutical aspects of drugs and clinical importance

Pharmacovigillance

Day 2.

Standard operation procedures during drug prescription

Day 3.

Special population PK/PD and clinical importance

Day 4.

Drug-drug interaction risk, PK/PD and toxicological significances

Day 5.

Importance and methods of therapeutic drug concentration monitoring in biological specimen